Skip to main content
. 2015 Aug 17;2015:960926. doi: 10.1155/2015/960926

Figure 4.

Figure 4

(a) Outline of the in vivo portion of the study. Heart function analysis showing both the (b) shortening fraction and (c) ejection fraction. Both measurements of heart function showed improvement in the CSC-XO treated groups 7 days following CSC-XO injection.